// App-Quantinova.ai

590 : Co-injection of human monocytes improves the in vivo antitumoral activity of bevacizumab in two NSCLC PDX models

Researchers

Presenter

  • Cordula Tschuch

Principal Investigators

  • Kerstin Klingner

  • Anne Lohr

  • Yana Raeva

  • Teppo Haapaniemi

  • Eva Oswald

  • Julia B. Schuler

Medical Centers

  • Oncotest GmbH, Freiburg, Germany

  • BioSiteHisto Oy, Tampere, Finland.

Locations

  • Finland

  • Germany

Companies

  • Oncotest GmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved